Effect of endotoxins isolated from Desulfovibrio desulfuricans soil and intestinal strain on the secretion of TNF-α by human mononuclear cells

Polish Journal of Environmental Studies

Volumn 15, Issue 4, 2006, Pages 615-622

  Weglarz, L ^a   Parfiniewicz, B ^a   Mertas, A ^a   Kondera Anasz, Z ^a   Jaworska Kik, M ^a   Dzierzewicz, Z ^a   Swiatkowska L ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Desulfovibrio desulfuricans; Lipopolysaccharides; Mononuclear cells; TNF

Indexed keywords

DESULFOVIBRIO DESULFURICANS; ESCHERICHIA COLI; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR MINNESOTA;

EID: 33748320881     PISSN: 12301485     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. GIBSON G.R. Physiology and ecology of the sulphate-reducing bacteria. J.Appl. Bacteriol. 69, 769, 1990.
2. DEVEREUX R., HE S.-H., DOYLE C.L., ORKLAND S., STAHL D.A., LeGALL J., WHITMAN W.B. Diversity and origin of Desulfovibrio species: phylogenetic definition of a family. J. Bacteriol. 172, 3609, 1990.
3. WIDDEL F., PFENNING N. Dissimilatory sulfate- or sulfur-reducing bacteria. In: Bergey's Manual of Systematic Bacteriology, Krieg N.R., Holt J.G (eds.). vol.1. Williams & Wilkins Co., Baltimore, pp 663-679, 1984.
4. FUDE L., HARRIS B., URRUTIA M.M., BEVERIDGE T.J. Reduction of Cr(VI) by a consortium of sulfate-reducing bacteria (SRB III). Appl. Environ. Microbiol. 60, 1525, 1994.
5. BEERENS H., ROMOND C. Sulfate-reducing anaerobic bacteria in human faeces. Am. J. Clin. Nutr. 30, 1770, 1977.
6. GIBSON G.R., MacFARLANE G.T., CUMMINGS J.H. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J. Appl. Bacteriol. 65, 103, 1988.
7. DZIERZEWICZ Z., GAWLIK B., CWALINA B., GONCIARZ K., ZIÓŁKOWSKI G., GONCIARZ Z., WILCZOK T. Activity of sulphate reducing bacteria in the human digestive tract. Bull. Pol. Acad. Sci. Biol. 42, 171, 1994.
8. FLORIN T.H.J., GIBSON G.R., NEALE G., CUMMINGS J.H. A role for sulphate-reducing bacteria in ulcerative colitis? Gastroenterology 98, A170, 1990.
9. GIBSON G.R., CUMMINGS J.H., MacFARLANE G.T. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol. Ecol. 86, 103, 1991.
10. McDOUGALL R.J., ROBSON J., PATERSON D., TEE W. Bacteremia caused by a recently described novel Desulfovibrio species. J. Clin. Microbiol. 35, 1805, 1997.
11. TEE W., DYALL-SMITH M., WOODS W., EISEN D. Probable new species of Desulfovibrio isolated from a pyogenic liver abscess. J. Clin. Microbiol. 34, 1760, 1996.
12. LOUBINOUX J., MORY F., PEREIRA I.A.C., LE FAOU A.E. Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis. J. Clin. Microbiol. 38, 931, 2000.
13. GOLDSTEIN E.J.C., CITRON D.M., PERAINO V.A., CROSS S.A. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. J. Clin. Microbiol. 41, 2752, 2003.
14. RIETSCHELE.T., BRADE H., HOLST O., BRADE L. Bacterial endotoxin: Chemical constitution, biological recognition, host response and immunological detoxification. p. 40-81. In: Pathology shock. Rietschel E.T., Wagner H. (eds.). Springer-Verlag, Berlin-Heidelberg-New York, pp 40-81, 1996.
15. ZHANG H., PETERSON J.W., NIESEL D.W., KLIMPEL G.R. Bacterial lipoprotein and LPS act synergistically to induce lethal shock and proinflammatory cytokine production. J. Immunol. 159, 4868, 1997.
16. BEATY C.D., FRANKLIN T.L., UEHARA Y., WILSON C.B. Lipopolysaccharide-induced cytokine production in human monocytes: role of tyrosine phosphorylation in transmembrane signal transduction. Eur. J. Immunol. 24, 1278, 1994.
17. DJEU J.Y., SERBOUSEK D., BLANCHRD K. Release of tumor necrosis factor by human polymorphonuclear leukocytes. Blood 76, 1405, 1990.
18. JANSKÝ L., REYMANOVÁ P., KOPECKÝ J. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol. Res. 52, 593, 2003.
19. BEUTLER B. TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med. 43, 227, 1995.
20. NANCEY S., BIENVENU J., COFFIN B., ANDRE F., DESCOS L., FLOURIÉ B. Butyrate strongly inhibits in vitro stimulated release of cytokines in blood. Dig. Dis. Sci. 47, 921, 2002.
21. SAËMANN M.D., BÖHMIG G.A., ÖSTERREICHER C.H., BURTSCHER H., PAROLINI O., DIAKOS C., STÖCKL J., HÖRL W.H., ZLABINGER G.J. Anti-inflammatory effects of sodium butyrate on human monocytes: Potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 14, 2380, 2000.
22. ULMER A.J., FLAD H., RIETSCHEL T., MATTERN T. Induction of proliferation and cytokine production in human T lymphocytes by lipopolysaccharide (LPS). Toxicology 152, 37, 2000
23. PLOTZ S.G., LENTSCHT A., BEHRENDT H., PLOTZ W., HAMANN L., RING J., RIETSCHEL E.T., FLAD H., ULMER A.J. The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 97, 235, 2001.
24. WRIGHT S.D., RAMOS R.A., TOBIAS P.S., ULEVITH R.J., MATHISON J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431, 1990.
25. BEUTLER B., DU HOEBE K.X., ULEVITCH R.J. How we detect microbes and respond to them. The Toll-like receptors and their transducers. J. Leukoc. Biol. 74, 479, 2003.
26. COUTURIER C., HAEFFNER-CAVAILLON N., CAROFF M., KAZATCHKINE M.D. Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J. Immunol. 147, 1899, 1991.
27. ROBERTSHAW H.J., BRENNAN F.M. Release of tumour necrosis factor α (TNFα) by TNFα cleaving enzyme (TACE) in response to septic stimuli in vitro. Br. J. Anaesth. 94, 222, 2005.
28. VAN LEEUWEN H.J., VAN DER TOL M., VAN STRIJP J.A.G., VERHOEF J., VAN KESSEL K.P.M The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood. Clin. Exp. Immunol. 140, 65, 2005.
29. ALLEN J.N., HERZYK D.J., WEWERS M.D. Human whole blood interleukin-1-beta production kinetics, cell source and comparison with TNF-alpha. J. Lab. Clin. Med. 119, 538, 1992.
30. VAN DER POLL T., COYLE S.M., MOLDAWER L.L., LOWRY S.F. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J. Infect. Dis. 174, 1356, 1996.
31. MITOV I.G., KROPEC A., BENZING A., JUST H., GAROTTA G., GALANOS C., FREUDENBER G.M. Differential cytokine production in stimulated blood cultures from intensive care patients with bacterial infections. Infect. 25, 206, 1997.
32. KARAHASHI H., AMANO F. Structure-activity relationship of lipopolysaccharides (LPS) in tumor necrosis factor (TNF-α) production and induction of macrophage cell death in the presence of cycloheximide (CHX) in a murine macrophage-like cell line J774. Biol. Pharm. Bull. 21, 1102, 1998.
33. WEGLARZ L., DZIERZEWICZ Z., ORCHEL A., SZCZERBA J., JAWORSKA-KIK M., WILCZOK T. Biological activity of Desulfovibrio desulfuricans lipopolysaccharides evaluated via interleukin-8 secretion by Caco-2 cells. Scan. J. Gastroenterol. 38, 73, 2003.
34. WEGLARZ L., DZIERZEWICZ Z., SKOP B., ORCHEL A. PARFINIEWICZ B., WIŚNIOWSKA B., ŚWIATKOWSKA L., WILCZOK T. Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression. Cell. Mol. Biol. Lett. 8, 991, 2003.
35. DZIERZEWICZ Z., CWALINA B., GAWLIK B., WILCZOK T. GONCIARZ Z. Isolation and evaluation of susceptibility to sulphasalazine of Desulfovibrio desulfuricans strains from the human digestive tract. Acta Microbiol. Pol. 46, 175, 1997.
36. POSTGATE J.R. The sulphate-reducing bacteria. 2nd ed., Cambridge University press, Cambridge, 1984.
37. WESTPHAL O., LUDERITZ O., BISTER F. Bacterial strains and isolation of bacterial lipopolysaccharides. Z. Naturforsch. 78, 148, 1952.
38. LAWDEN K.H., PITTS J.M., THOMAS J.A., LOWE C.R. Rational computeraided design of ligands that bind endotoxin. In: Bacterial endotoxins: Lipopolysaccharides from genes to therapy. Levin J., Alving C.R., Munford R.S., Redl H. (eds.). Wiles-Liss, Inc. pp 443-452, 1995.
39. BOYÜM A. Separation of lymphocytes, granulocytes and monocytes from human blood using iodinated density gradient media. In: Meth. Enzymol. Di Sabato G., Langone J.J., Van Vunakis H. (eds.). Academic Press, New York, London, vol. 108, 88, 1984.
40. LEMAIRE L.C., VAN LANSCHOT J.J., STOUTENBEK C.P., VAN DEVENTER S.J., WELLS C.L. Bacterial translocation in multiple organ failure: Cause or epiphenomenona still unproven. Br. J. Surg. 84, 1340, 1997.
41. VAN DEVENTER J.H., BULLER H.R., TEN CATE J.W., STURK A., PAUW W. Endotoxaemia: an early predictor of septicemia in febrile patients. Lancet 1, 605, 1988.
42. TROELSTRA A., ANTAL-SZALMAS P., DE GRAAF-MILTENBURG L.A.M., WEERSINK A.J.L., VERHOEF J., VAN KESSEL K.P.M., VAN STRIJP J.A.G. Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes. Infect. Immun. 65, 2272, 1997.
43. WEERSINK A.J.L., VAN KESSEL K.P.M., TORENSMA R., VAN STRIJP J.A.G., VERHOEF J. Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibodies. J. Immunol. 145, 318, 1990.
44. CORRALES L.A.J., WEERSINK A.J.L., VERHOEF J., VAN KESSEL K.P.M. Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14. Immunology 80, 84, 1993.
45. HEUMANN D., GALLAY P., BARRAS C., ZAECH P., ULEVITCH R.J., TOBIAS P.S., GLAUSER M.-P., BAUMGARTNER J.D. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. J. Immunol. 148, 3505, 1992.
46. WARNER S.J.C., SAVAGE N., MITCHELL D. Characteristics of lipopolysaccharide interaction with human peripheral-blood monocytes. Biochem. J. 232, 379, 1985.
47. MUELLER M., BRANDENBURG K., DEDRICK R., SCHROMM A.B., SEYDEL U. Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein J. Immunol. 174, 1091, 2005
48. WEIDEMANN B., BRADE H., RIETSCHEL E.T., DZIARSKI R., BAZIL V., KUSUMOTO S., FLAD H.D., ULMER A.J. Soluble peptidoglycan induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62, 4709, 1994
49. AYBAY C., IMIR T. Comparison of the effects of Salmonella minnesota Re595 lipopolysaccharide, lipid A and monophosphoryl lipid A on nitric oxide, TNF-α and IL-6 induction from RAW 264.7 macrophages. FEMS Immunol. Med. Microbiol. 22, 263, 1998.
50. MUOTIALA A., HALANDER I.M., PYHALA L., KOSUNEN T., MORAN A.P. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 60, 1714, 1992.
51. GAYLARDE C.C., BEECH I.B. Short communication: Lipopolysaccharide composition of Desulfovibrio cell wall. World J. Microbiol. Biotechnol. 12, 113, 1996.
52. LODOWSKA J., WOLNY D., JAWORSKA-KIK M., WEGLARZ L., DZIERZEWICZ Z, WILCZOK T. Composition of the polysaccharide component of the endotoxin from the intestinal strain of Desulfovibrio desulfuricans. Ann. Pol. Chem. Soc. 2, 299, 2003.
53. SMIRNOVA I., POLTORAK A., CHAN E.K.L., McBRIDE C., BEUTLER B. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol. 1, 2001, 2000
54. DZIERZEWICZ Z., SZCZERBA J., WEGLARZ L., ŚWIATKOWSKA L., JASIŃSKA D., WILCZOK T. Intraspecies variability of Desulfovibrio desulfuricans strains determined by the genetic profiles. FEMS Lett. 219, 69, 2003
55. DZIERZEWICZ Z., SZCZERBA J., WEGLARZ L., KOMARSKA-SZOSTAK A., WILCZOK T. Evaluation of arbitrarily primed PCR for typing of Desulfovibrio desulfuricans strains. Microbiol. Res. 158, 173, 2003
56. VAISHTEIN M., HIPPE H., KROPPENSTEDT R.M. Cellular fatty acid composition of Desulfovibrio species and its use in classification of sulfate-reducing bacteria. Syst. Appl. Microbiol. 15, 554, 1992
57. DZIERZEWICZ Z., CWALINA B., KURKIEWICZ S., CHODUREK E., WILCZOK T. Intraspecies variability of cellular fatty acids among soil and intestinal strains of Desulfovibrio desulfuricans. Appl. Environ. Microbiol. 62, 33605, 1996
58. DZIERZEWICZ Z., CWALINA B., JAWORSKA-KIK M., WEGLARZ L., WILCZOK T. Susceptibility to antibiotics and biochemical properties of Desulfovibrio desulfuricans strains. Acta Pol. Pharm. 58, 439, 2001